Last reviewed · How we verify
Drug Metabolizing Enzyme
At a glance
| Generic name | Drug Metabolizing Enzyme |
|---|---|
| Sponsor | OrsoBio, Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Telecommunication Technology-based Online Survey
- Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes (PHASE1)
- Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure
- Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing (NA)
- DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers
- Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults
- A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants (PHASE1)
- Voriconazole Blood Level and Liver Metabolizing Enzyme in Taiwanese Patients
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Drug Metabolizing Enzyme CI brief — competitive landscape report
- Drug Metabolizing Enzyme updates RSS · CI watch RSS
- OrsoBio, Inc portfolio CI